ScreenerHero

IMU Imugene Limited

ASX · AU · Healthcare · Biotechnology · imugene.com
—Mkt Cap: —P/E: —

Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under develop…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value14.06M USD
Revenue (TTM)1.44M USD
Gross Profit1.44M USD
Net Income (TTM)-47.70M USD
Revenue/Share0.0060 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees14
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000IMU9
Valuation
P/E (Trailing)—
P/E (Forward)-0.88
PEG4.07
EV/EBITDA-0.20
EV/Revenue9.75
P/S9.08
P/B1.55
EPS (TTM)-0.30
EPS (Forward)-0.04
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-5246.19%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-153.27%
ROA-82.57%
Growth
Revenue Growth-59.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-30.92M USD
CapEx (TTM)9.99M USD
FCF Margin-2509.75%
FCF Yield—
Net Debt2.53M USD
Net Debt/EBITDA-0.04
Balance Sheet
Debt/Equity0.24
Current Ratio0.70
Quick Ratio0.36
Book Value/Sh0.02 AUD
Cash/Share0.0050 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:34
Split DateJul 2, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.2300 AUD
Target Range0.1600 AUD – 0.2800 AUD
# Analysts3
Ownership
Shares Out.557.27M
Float438.21M
Insiders9.31%
Institutions9.52%
Technical
SMA 500.0588 AUD
SMA 2000.1395 AUD
Beta2.24
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)4.79M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—